AzTrials
AzTrials

Total Knee ReplacementGAP-FlexNCT02670499

Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR

A study testing CPM and GAPFLEX in people with Total Knee Replacement, run by Xeras Medical Technologies at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Post Market TKR study Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
Conditions the study is for
Total Knee Replacement
What is being tested?
CPM and GAPFLEX
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
2 sitesUnited States
Study dates
18 Nov 2015to 23 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Minimum age 50 years
  • Subject is undergoing total knee replacement
  • Subject agrees to comply with the physical therapy regime

Who cannot join

  • With a flexure contracture > 10 degrees
  • Degree of flexion < 60 degrees pre-procedure or immediately post-procedure
  • Severe motion restriction as determined by the investigator
  • Severe deformity determined by the investigator
  • Taking chronic pain medication for use other than knee pain
  • Post surgery hospital stay is > 4 days
Show all 23Show fewer
  • Knee disorders other than osteoarthritis
  • With fibromyalgia
  • Chronic narcotic use as determined by the investigator.
  • Have a medical or psychological history that in the opinion of the investigator would make the subject a poor candidate for the study.
  • Who need a revision implant
  • Who have participated in clinical study within the past 30 days (prior to enrollment) that may affect the outcome of this study
  • Amputations below or above knee of non-operated leg
  • Weight is >250 pounds and/or morbidly obese (BMI > 40)
  • History of blood clots
  • Deep vein thrombosis
  • Females who are pregnant
  • Females who wish to become pregnant during the length of study participation
  • Subjects with any of the following post-surgery conditions;
  • Screws needed
  • Intraoperative identification of a fracture or soft bone
  • Admitted to ICU
  • Additional procedures (other than TKR) needed for other identified or pre-existing conditions

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Nix Orthopaedic Center

    San Antonio, Texas, 78205

  • Orthopaedic Institute

    San Antonio, Texas, 78260

Other trials in United States

About this study

Official title: A Randomized Controlled Multicenter Study Comparing GAP-FLEX to Continuous Passive Motion (CPM) Therapy in Combination With Standard of Care Physical Therapy in Subjects With Total Knee Replacement (TKR)

Post Market TKR study

Read the detailed description

A post-market study to evaluate the safety and effectiveness of the GAP-FLEX device in combination with standard of care physical therapy compared to the standard of care CPM device in combination with standard of care physical therapy in Subjects who have undergone TKR

Being tested
CPM, GAPFLEX

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CPMDevice

    Also called Continuous Passive Motion Device

    Used to aid in recovery from TKR

  • GAPFLEXDevice

    Used to aid in the recovery of TKR

Study groups in NCT02670499
Study groupRoleWhat they receive
GAP-FLEXExperimentalStudy Device will be used up to 6 times per day for up to 6 minutes to aid in the recovery and improve the degree of flexion from TKR
Receives: Device: GAPFLEX
CPMActive comparatorControl Device will be used up to 2 hours per day for up to 3 times per day to aid in the recovery and improve the degree of flexion from TKR and be compared to the Study Device
Receives: Device: CPM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Flexion

    improvement in week 4 visit degree of flexion measured by Goniometer in the GAP-FLEX group will be compared to the CPM

    Measured: Degree of flexion achieved at week 4 visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2016 (estimated)
  2. Study start18 Nov 2015
  3. Primary completion7 Feb 2017
  4. Study completion23 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02670499
Sponsor's protocol ID
GPF2015-01
Acronym
GAP-Flex
Status last verified
Jun 2017
First submitted
4 Sep 2015
Last updated
27 Jun 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CPM and GAPFLEX in people with Total Knee Replacement, run by Xeras Medical Technologies at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Flexion (time frame: Degree of flexion achieved at week 4 visit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in